Is Esperion Therapeutics Inc (NASDAQ: ESPR) Back In The Buying Zone?
Currently, there are 195.44M common shares owned by the public and among those 195.08M shares have been available to trade. The company’s stock has a 5-day price change of 4.11% and 20.63% over the past three months. ESPR shares are trading 3.64% year to date (YTD), with the 12-month market performance down to -17.09% lower. […]
Value Hunters: Look To Esperion Therapeutics Inc (ESPR)
Currently, there are 195.44M common shares owned by the public and among those 195.08M shares have been available to trade. The company’s stock has a 5-day price change of -1.83% and 30.30% over the past three months. ESPR shares are trading -28.09% year to date (YTD), with the 12-month market performance down to -30.19% lower. […]
Analysts Update Their Price Forecasts For Esperion Therapeutics Inc (ESPR)
Esperion Therapeutics Inc (ESPR) concluded trading on Thursday at a closing price of $2.32, with 4.17 million shares of worth about $9.67 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.43% during that period and on December 26, 2024 the price saw a […]
Esperion Therapeutics Inc (NASDAQ: ESPR) – Suitable For Long Term Buy?
Currently, there are 195.44M common shares owned by the public and among those 195.06M shares have been available to trade. The company’s stock has a 5-day price change of -35.34% and 27.84% over the past three months. ESPR shares are trading -24.75% year to date (YTD), with the 12-month market performance up to 49.01% higher. […]
Esperion Therapeutics Inc (ESPR) Volatility Spurs A Quest For Clarity
Currently, there are 195.44M common shares owned by the public and among those 195.06M shares have been available to trade. The company’s stock has a 5-day price change of -6.46% and 74.71% over the past three months. ESPR shares are trading 1.67% year to date (YTD), with the 12-month market performance up to 104.03% higher. […]
Institutional Exposure To Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.61, with 4.62 million shares of worth about $12.07 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.35% during that period and on Wednesday the price saw a loss of […]
Esperion Therapeutics Inc. (NASDAQ: ESPR) Stock In Prove Me State
Esperion Therapeutics Inc. (ESPR) concluded trading on Thursday at a closing price of $2.66, with 2.99 million shares of worth about $7.95 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 73.86% during that period and on Thursday the price saw a gain of […]
Do Esperion Therapeutics Inc. (NASDAQ: ESPR) Fit In A Value Investing Philosophy?
Currently, there are 170.42M common shares owned by the public and among those 169.06M shares have been available to trade. Insiders at the company have transacted a total of 31 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, […]
Growth Story Still Intact For Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.14, with 6.62 million shares of worth about $14.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 26.63% during that period and on Wednesday, January 31 the price saw a […]
Esperion Therapeutics Inc. (NASDAQ: ESPR): Hunting Genuine Value In Market Debris
Two Seas Capital LP recently announced the acquisition of new stake in Esperion Therapeutics Inc. (NASDAQ:ESPR). The institutional investor has increased its shareholding in the Healthcare company by 160.79% to 7.67 million shares with purchase of 4.73 million shares. This fresh investment now brings its stake to 6.75% valued currently at $22.94 million. In addition, […]
